Sign up to save your podcasts
Or
Share Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
View all episodes
By Erin Harris
4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
More shows like Cell & Gene: The Podcast
View all
Fareed Zakaria GPS
3,447 Listeners
Nature Podcast
756 Listeners
HBR IdeaCast
154 Listeners
Science Magazine Podcast
818 Listeners
The Daily
113,121 Listeners
Today, Explained
10,331 Listeners
The Readout Loud
337 Listeners
Short Wave
6,592 Listeners
The Prof G Pod with Scott Galloway
5,610 Listeners
Consider This from NPR
6,462 Listeners
Business Of Biotech
85 Listeners
Hard Fork
5,576 Listeners
The Weekly Show with Jon Stewart
11,013 Listeners
ASGCT Podcast Network
16 Listeners
Prof G Markets
1,480 Listeners